Vericel Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,059.00
30,343.00
14,581.00
22,978.00
26,862.00
82,924
Total Accounts Receivable
-
8,191.00
10,919.00
17,093.00
18,270.00
23,454
Inventories
-
1,920.00
1,379.00
3,488.00
3,793.00
3,558
Other Current Assets
417.00
1,036.00
464.00
1,164.00
1,581.00
2,847
Total Current Assets
8,476.00
41,490.00
27,343.00
44,723.00
50,506.00
112,783
Net Property, Plant & Equipment
739.00
2,892.00
4,049.00
3,875.00
4,071.00
5,906
Intangible Assets
-
3,197.00
2,917.00
-
-
-
Total Assets
9,215.00
47,579.00
34,309.00
48,598.00
54,577.00
118,689
ST Debt & Current Portion LT Debt
6.00
-
-
779.00
350.00
Accounts Payable
2,355.00
5,824.00
7,588.00
6,535.00
5,552.00
Other Current Liabilities
2,960.00
6,005.00
4,520.00
5,539.00
7,188.00
Total Current Liabilities
5,321.00
11,829.00
12,108.00
12,853.00
13,090.00
Long-Term Debt
-
-
71.00
9,350.00
16,888.00
Other Liabilities
-
109.00
-
1,687.00
2,059.00
Total Liabilities
5,321.00
11,938.00
12,179.00
23,890.00
32,037.00
Common Equity (Total)
34,495.00
2,748.00
19,409.00
13,681.00
22,540.00
Total Shareholders' Equity
3,894.00
35,641.00
22,130.00
24,708.00
22,540.00
Total Equity
3,894.00
35,641.00
22,130.00
24,708.00
22,540.00
Liabilities & Shareholders' Equity
9,215.00
47,579.00
34,309.00
48,598.00
54,577.00
Preferred Stock (Carrying Value)
38,389.00
38,389.00
41,539.00
38,389.00
-

About Vericel

View Profile
Address
64 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.vcel.com
Updated 07/08/2019
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio include MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee.